HRAS mutation as a diagnostic molecular analysis for epithelial-myoepithelial carcinoma of the parotid gland: A case report.

Yasuda, Taisei; Osaki, Masami; Sugitani, Masahiko

HRAS mutation as a diagnostic molecular analysis for epithelial-myoepithelial carcinoma of the parotid gland: A case report.

Yasuda, Taisei; Osaki, Masami; Sugitani, Masahiko.

Afiliación

Yasuda T; Department of Otolaryngology-Head and Neck Surgery Ageo Central General Hospital Saitama Japan.
Osaki M; Department of Otolaryngology-Head and Neck Surgery Ageo Central General Hospital Saitama Japan.
Sugitani M; Department of Pathology Ageo Central General Hospital Saitama Japan.

Clin Case Rep ; 11(10): e8099, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37881200

ABSTRACT

ABSTRACT

HRAS mutations are frequent genetic alterations in epithelial-myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.

Palabras clave

HRAS mutation; epithelialmyoepithelial carcinoma; salivary gland carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2023 Tipo del documento: Article